Aptevo Therapeutics Inc. 10-K filing
Filed 2026-03-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-126278
- Form type
- 10-K
- CIK
- 0001671584
- Primary document
- https://www.sec.gov/Archives/edgar/data/1671584/000119312526126278/apvo-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aptevo Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-26.3M | - | - |
| Net Income | $-26.0M | - | - |
| Eps Basic | -87.27 | - | - |
| Eps Diluted | -87.27 | - | - |
| Cash And Equivalents | $21.6M | - | - |
| Total Assets | $27.2M | - | - |
| Total Liabilities | $9.8M | - | - |
| Shareholders Equity | $17.4M | - | - |
| Operating Cash Flow | $-25.6M | - | - |